血清STARD4-AS1作为胃癌诊断的新标记物,并促进胃癌的进展
Xiuyu Chu1,2, Min Cao3, Xinyue Qin4
1Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.
Clinical and translational gastroenterology
|September 3, 2025
概括
血清STARD4-AS1显示为胃癌 (GC) 检测和预后的生物标志物. 较高的水平与较差的生存率相关,并且在与现有标志物相结合时可以提高诊断的准确性.
科学领域:
- 癌症学
- 分子生物学
- 生物标志物发现
背景情况:
- 胃癌是癌症死亡的主要原因,
- 长非编码RNAs (lncRNAs) 涉及癌症进展,表明它们作为治疗点或生物标记物的潜力.
- STARD4-AS1是一种lncRNA,其在胃癌中的作用需要研究.
研究的目的:
- 研究STARD4-AS1作为胃癌的潜在诊断生物标志物.
- 探索STARD4-AS1在胃癌发展中的功能作用和潜在机制.
- 在胃癌患者中评估STARD4- AS1的预后价值.
主要方法:
- 癌症基因组图谱 (TCGA) 数据库的全癌症分析以确定STARD4-AS1.
- 定量实时PCR (qRT-PCR) 用于测量患者的血清STARD4- AS1水平.
- 接收器操作特征 (ROC) 曲线分析用于诊断效率评估.
- 试验室功能实验 (例如,敲击) 和西部抹除以确定生物作用.
- 用于探索机制和免疫治疗相关性的生物信息学分析.
主要成果:
- 在胃癌患者中,较高的STARD4- AS1表达与较低的整体存活率有关.
- 与健康患者和胃炎患者相比,血清STARD4- AS1水平显著升高.
- 在GC检测方面,STARD4-AS1表现优于CEA,CA199和CA724,特别是在组合中.
- 阻断STARD4- AS1抑制了GC细胞的增殖,转移和上皮- 介质细胞的转变.
- STARD4- AS1表达预测了预后,并且可以通过酸和跨膜受体蛋白酸酶信号通路调节GC.
结论:
- 血清STARD4-AS1是一种有前途的胃癌诊断生物标志物.
- 在胃癌的进展中,STARD4-AS1表现出致癌功能.
- STARD4-AS1有可能改善GC诊断,监测和预后评估.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.2K
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
4.5K
相关概念视频
01:30Serum Laboratory Studies, Stool Test, Breath Test
473
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
473
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K